ProCE Banner Activity

Progress (or Not) Toward Zero Infections in 2030: My Take From EACS

Conference Coverage
Clinical Thought
Here’s why I’m concerned by data on rates of virologic suppression in Europe.

Released: November 22, 2021

Expiration: November 21, 2022

No longer available for credit.

Share

Faculty

Tristan J. Barber

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare

Faculty Disclosure

Primary Author

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Tristan J. Barber, MA, MD, FRCP, has disclosed that he has received funds for research support from Roche; consulting fees from Gilead Sciences, MSD, Theratechnologies, and ViiV; fees for non-CME/CE services from Gilead Sciences, MSD, and ViiV; and other financial or material support from Gilead Sciences and ViiV.